Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation

International Journal of Pharmaceutics

Volumn 272, Issue 1-2, 2004, Pages 65-78

  Kofuji, K ^a   Akamine, H ^a   Qian, C J ^a   Watanabe, K ^a   Togan, Y ^a   Nishimura, M ^a   Sugiyama, I ^a   Murata, Y ^a   Kawashima, S ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Air pouch; Biodegradation; Chitosan; Inflammation; Sustained release

Indexed keywords

AMINO ACID; CARRAGEENAN; CHITOSAN; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DEGRADATION; DRUG DIFFUSION; DRUG EFFICACY; DRUG IMPLANTATION; DRUG RETENTION; DRUG SYNTHESIS; GEL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION;

ADJUVANTS, PHARMACEUTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAPILLARY PERMEABILITY; CARRAGEENAN; CHITIN; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; GELS; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED STRAINS; PREDNISOLONE; SKIN; SOLUBILITY;

EID: 1442348854     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.11.036     Document Type: Article

References (24)

1. Carreño-Gómez B., Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int. J. Pharm. 148:1997;231-240.
2. Golomb G., Levi M., Gelder J.M.V. Controlled release of bisphosphonate from a biodegradable implant: evaluation of release kinetics and anticalcification effect. J. Appl. Biomater. 3:1992;23-28.
3. Hambleton P., Miller P. Studies on carrageenin air pouch inflammation in the rat. Br. J. Exp. Pathol. 70:1989;425-433.
4. He P., Davis S.S., Illum L. Chitosan microspheres prepared by spray drying. Int. J. Pharm. 187:1999;53-65.
5. Jameela S.R., Jayakrishnan A. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials. 16:1995;769-775.
6. Khor E., Lim L.Y. Implantable applications of chitin and chitosan. Biomaterials. 24:2003;2339-2349.
7. Kim M.S., Sung M.J., Seo S.B., Yoo S.J., Lim W.K., Kim H.M. Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid β peptide and interleukin-1β Neurosci. Lett. 321:2002;105-109.
8. Kofuji K., Shibata K., Murata Y., Miyamoto E., Kawashima S. Preparation and drug retention of biodegradable chitosan gel beads. Chem. Pharm. Bull. 47:1999;1494-1496.
9. Kofuji K., Ito T., Murata Y., Kawashima S. The controlled release of a drug from biodegradable chitosan gel beads. Chem. Pharm. Bull. 48:2000;579-581.
10. Kofuji K., Ito T., Murata Y., Kawashima S. Biodegradation and drug release of chitosan gel beads in subcutaneous air pouches of mice. Biol. Pharm. Bull. 24:2001;205-208.
11. Kofuji K., Ito T., Murata Y., Kawashima S. Effect of chondroitin sulfate on the biodegradation and drug release of chitosan gel beads in subcutaneous air pouches of mice. Biol. Pharm. Bull. 25:2002;268-271.
12. Kofuji K., Akamine H., Oshirabe H., Maeda Y., Murata Y., Kawashima S. Retention and release behavior of insulin in chitosan gel beads. J. Biomater Sci. Polymer. Edn. 14:2003;1243-1253.
13. Lahiji A., Sohrabi A., Hungerford D.S., Frondoza C.G. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J. Biomed. Mater. Res. 51:2000;586-595.
14. Lu J.X., Prudhommeaux F., Meunier A., Sedel L., Guillemin G. Effects of chitosan on rat knee cartilages. Biomaterials. 20:1999;1937-1944.
15. Okamoto Y., Kawakami K., Miyatake K., Morimoto M., Shigemasa Y., Minami S. Analgesic effects of chitin and chitosan. Carbohydr. Polym. 49:2002;249-252.
16. Onishi H., Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials. 20:1999;175-182.
17. Oungbho K., Müller B.W. Chitosan sponges as sustained release drug carriers. Int. J. Pharm. 156:1997;229-237.
18. Remuñan-López C., Portero A., Lemos M., Vila-Jato J.L., Nuñez M.J., Riveiro P., López J.M., Piso M., Alonso M.J. Chitosan microspheres for the specific delivery of amoxycillin to the gastric cavity. S.T.P. Pharm. Sci. 10:2000;69-76.
19. Suh J.K.F., Matthew H.W.T. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials. 21:2000;2589-2598.
20. Thanoo B.C., Sunny M.C., Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol. 44:1992;283-286.
21. Tokumitsu H., Ichikawa H., Fukumori Y., Block L.H. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chem. Pharm. Bull. 47:1999;838-842.
22. Tomihata K., Ikada Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials. 18:1997;567-575.
23. Williams R.O. III, Barron M.K., Alonso M.J., Remuñán- López C. Investigation of a pMDI system containing chitosan microspheres and P134a. Int. J. Pharm. 174:1998;209-222.
24. Yomota C., Komuro T., Kimura T. Studies on the degradation of chitosan films by lysozyme and release of loaded chemicals. Yakugaku Zasshi. 110:1990;442-448.